Stephanie Graff, MD, FACP, FASCO· @DrSGraff · X·· 2 天前评分70
正文 · 原文
HORIZON-Breast06 confirms benefit of trastuzumab *rezetecan* in a DB06-like patient population—HER2low, chemo-naive
#ESMO26 @OncoAlert
572 浏览 · 12 赞 · 9 转发 · 0 回复
会议摘要
LBA13按 Proffered paper 1: Breast cancer, early and advanced stage 对上
Trastuzumab rezetecan (SHR-A1811) in HER2-low advanced breast cancer (BC): A randomized, phase 3 study (HORIZON-Breast06)
https://esmocongress.esmo.org来源：Stephanie Graff, MD, FACP, FASCO · x.com